Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 26 May 2026

Tuesday, 26 May 2026

Ceisteanna (1455)

Ken O'Flynn

Ceist:

1455. Deputy Ken O'Flynn asked the Minister for Health whether Ireland currently operates a distinct reimbursement or pharmacoeconomic assessment pathway for orphan medicines or ultra-rare disease therapies; if so, to provide details of the framework and criteria applied; and if she will make a statement on the matter. [39835/26]

Amharc ar fhreagra

Freagraí scríofa

Ireland operates a reimbursement and pharmacoeconomic assessment pathway as outlined in the Health (Pricing and Supply) of Medical Goods Act, 2013. Health (Pricing and Supply of Medical Goods) Act 2013

Roinn